Overall Technical outlook

Price Summary

2025-07-16, saw MANKIND's stock open at 2653.9, hit a peak of 2654.2, fall to a low of 2598.0, and close down -1.07% at 2625.5, with 729597 shares changing hands.
Over the course of 52 weeks, the stock peaked at 2998.4 and hit a low of 1990.4.
The future price of MANKIND is projected to range from 2150.0 to 3300.0, with an average expected price of 2712.4707, according to 17 analysts.

Technicals


Aroon: The AROON is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
MANKIND aroon 86556e
Aroon chart for Mankind Pharma Limited


Bol. Bands: The BOLL BANDS is in a neutral stance, with no clear direction indicated for the market. This lack of clarity suggests that the market may be in a state of equilibrium for MANKIND, with no strong trend emerging.
MANKIND bbands 86556e
Bolinger Bands chart for Mankind Pharma Limited


Parabolic SAR: The PSAR continues to be bullish for MANKIND, setting a strong support level that could sustain the ongoing upward trend. This level of support indicates that the market is likely to continue its positive trajectory, offering a base for continued bullish movement.
MANKIND psar 86556e
Parabolic Stop and Reverse chart for Mankind Pharma Limited


Stochastic: The stochastic indicator for MANKIND reflects the K-line moving below the D-line, though it stays above 80, hinting at the potential beginning of a bearish price move. This setup suggests that the market's strength may be diminishing, with a possible downturn ahead. Traders should be on alert for further bearish confirmation.
MANKIND stoch 86556e
Stochastic chart for Mankind Pharma Limited


Tripple Moving Agerage: The Tripple MOVING AVG is currently in a neutral position for Mankind Pharma Limited, offering no clear guidance on whether the market is likely to move up or down. This neutral stance suggests that further observation may be necessary before a trend becomes apparent.
MANKIND trippleSMA 86556e
Tripple SMA chart for Mankind Pharma Limited


When evaluating a company's technical data, such as stock price charts or volume, it is essential to first consider its fundamentals. These fundamentals include financial stability, growth potential, and competitive advantages. Additionally, understanding the broader industry in which the company operates offers context that helps to make sense of technical patterns. By examining both the company's internal strengths and external environment, one can make more accurate and meaningful conclusions about its stock performance.